Certain low-risk or mature devices may see reduced trial requirements, but the broader trend is toward augmenting—not ...
Three reasons why substituting real world data for certain randomized clinical trials is inevitable The 21st Century Cures Act and planned Prescription Drug User Fee Act (PDUFA) VI are changing the ...
In today's healthcare environment, securing regulatory approval is only the beginning. The real challenge lies in ensuring ...
Pragmatic clinical trials are designed to evaluate the effectiveness of interventions under the conditions of routine clinical practice, thereby addressing the gap between traditional randomised ...
Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived ...
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
The U.S. is giving $1.6 million to researchers to study how the hepatitis B vaccine affects newborns in Guinea-Bissau. Local ...
We preselected all newsletters you had before unsubscribing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results